Covid-19 vaccine 'Covishield' has been in headlines from past several months in India and it is again in headlines due to legal battle initiated by Cutis Biotech against Serum Institute of India Pvt. Ltd. Recently, Cutis Biotech (hereinafter referred to as Plaintiff) filed a commercial suit in a Civil Court